Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes
Journal of Diabetes Investigation · 2024-04 · 15 (4) · 429-436
DOI: 10.1111/jdi.14142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 19.01.2024. Verfasst von Yusuke Shiozaki-Takagi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan. Hauptthemen laut MEDLINE: Glucagon, Hepatocytes, Benzene Derivatives, Sulfones. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Aims/Introduction Glucagon plays an essential role in hepatic glucogenesis by enhancing glycogen breakdown, inducing gluconeogenesis, and suppressing glycogenesis. Moreover, glucagon increases cyclic adenosine monophosphate (cAMP) levels, thereby activating protein kinase A (PKA) and cAMP guanine nucleotide exchange factor (also known as Epac). Although the function of PKA in the liver has been studied extensively, the function of hepatic Epac is poorly understood. The aim of this study was to elucidate the role of Epac in mediating the action of glucagon on the hepatocytes. Materials and Methods Epac mRNA and protein expression, localization, and activity in the hepatocytes were analyzed by reverse transcription polymerase chain reaction, western blotting, immunofluorescence staining, and Rap1 activity assay, respectively. Additionally, we investigated the effects of an Epac‐specific activator, 8‐CPT, and an Epac‐specific inhibitor, ESI‐05, on glycogen metabolism in isolated rat hepatocytes. Further mechanisms of glycogen metabolism were evaluated by examining glucokinase (GK) translocation and mRNA expression of gluconeogenic enzymes.
Results
Epac2, but not Epac1, was predominantly expressed in the liver. Moreover, 8‐CPT inhibited glycogen accumulation and GK translocation and enhanced the mRNA expression of gluconeogenic enzymes. ESI‐05 failed to reverse glucagon‐induced suppression of glycogen storage and partially inhibited glucagon‐induced GK translocation and the mRNA expression of gluconeogenic enzymes.
Conclusions
Epac signaling plays a role in mediating the glucogenic action of glucagon in the hepatocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Center of Health, Physical Fitness and Sports, Nagoya University, Nagoya, Japan.
- Department of Pathobiochemistry, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
- Division of Endocrinology, Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital, Nagoya, Japan.
ORCID-Profile: Yusuke Shiozaki-Takagi, Nobuaki Ozaki
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shiozaki-Takagi, Y., Ozaki, N., & Toyoda, Y. (2024). Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes. Journal of Diabetes Investigation, 15(4), 429-436. https://doi.org/10.1111/jdi.14142
Vancouver
Shiozaki-Takagi Y, Ozaki N, Toyoda Y. Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes. Journal of Diabetes Investigation. 2024;15(4):429-436. doi:10.1111/jdi.14142
BibTeX
@article{ShiozakiTakagi2024,
author = {Shiozaki-Takagi, Yusuke and Ozaki, Nobuaki and Toyoda, Yukiyasu},
title = {Epac2 activation mediates glucagon‐induced glucogenesis in primary rat hepatocytes},
journal = {Journal of Diabetes Investigation},
year = {2024},
volume = {15},
number = {4},
pages = {429--436},
doi = {10.1111/jdi.14142}
}
EUVIMED